Fig. 3From: Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluationScatterplot illustrating incremental costs versus incremental benefits (QALYs) for a 1-year, 2-year, and 5-year follow-up time horizon (n = 1,000 simulations, healthcare payer perspective, Germany)Back to article page